relative to treatment alternatives to opioids.

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text History 6 Sponsors 5

No summary has been published for this bill.

Chamber: House
Introduced: Jan 9, 2021
Last action: Nov 3, 2021 — Committee Report: Refer for Interim Study HB247 10/26/2021 (Vote 21-0; CC)
Sponsor: David Lundgren R
Session: 2021
Momentum: 39 · Low

PASSAGE PROBABILITY

7.7% Unlikely

Why this number

Stage base In Committee — base rate 27%, measured from NH's completed sessions
Momentum -2 39/100 from the pace of recorded action
Time since last action -22 1802 days quiet
Cosponsors +6 4 signed on
Sponsor influence -0 48/100

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.